Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | -3.72% | -5.04% | -3.42% |
05-14 | Earnings Flash (OVID) OVID THERAPEUTICS Posts Q1 Revenue $148,000 | MT |
05-14 | Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.42% | 229M | |
+10.27% | 115B | |
+12.64% | 106B | |
-4.70% | 24.69B | |
-2.01% | 21.97B | |
-5.61% | 19.27B | |
-11.76% | 17.56B | |
-39.36% | 17.32B | |
+5.97% | 14.03B | |
+32.15% | 12.13B |
- Stock Market
- Equities
- OVID Stock
- News Ovid Therapeutics Inc.
- Ovid Therapeutics, Graviton Bioscience Working Together to Create New Medicines for Neurological Diseases